Publicacions
-
Rubio-Valera M, Marqués-Ercilla S, Peñarrubia-María MT, Urbanos-Garrido RM, Borrell C, Bosch J, Sanchez A and Aznar I.
Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region.
FRONTIERS IN PHARMACOLOGY . 12: 617687-617687.
-
Iglesias M, Gil MM, Peñarrubia-María MT, Blanco-García E, Fernández-Vergel R, Serrano-Blanco A, Carbonell-Duacastella C, Alonso J and Rubio-Valera M.
Barriers and opportunities for the treatment of mild-to-moderate depression with a watchful waiting approach.
PATIENT EDUCATION AND COUNSELING . 104(3): 611-619. Nº de cites: 4
-
González Suñer L, Carbonell-Duacastella C, Aznar I, Rubio-Valera M, Iglesias M, Peñarrubia-María MT, Gil MM and Serrano-Blanco A.
Use of Mental Health Services for Patients Diagnosed with Major Depressive Disorders in Primary Care
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 18(3): . Nº de cites: 3
-
Vilaplana Carnerero C, Aznar I, Peñarrubia-María MT, Serrano-Blanco A, Fernández-Vergel R, Petitbò-Antúnez D, Gil MM, March MA, Mendive JM, Sanchez A, Carbonell-Duacastella C and Rubio-Valera M.
Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 17(10): . Nº de cites: 5
-
Gil MM, Aznar I, Peñarrubia-María MT, Moreno-Peral P, Fernández A, Bellón JÁ, Jové AM, Mendive JM, Fernández-Vergel R, Figueiras A, March MA and Rubio-Valera M.
Reasons for medication non-initiation: A qualitative exploration of the patients' perspective.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY . 16(5): 663-672. Nº de cites: 14
-
Francesco D'Amico, Feliu A, Montero-Marín J, Peñarrubia-María MT, Navarro-Gil M, Van Gordon W, García-Campayo J and Luciano JV.
Cost-Utility of Attachment-Based Compassion Therapy (ABCT) for Fibromyalgia Compared to Relaxation: A Pilot Randomized Controlled Trial.
Journal of Clinical Medicine . 9(3): . Nº de cites: 7
-
Carbonell Duacastella, Cristina, Aznar I, Gil MM, Peñarrubia-María MT, Gallardo C, Planchuelo D, Jiménez B, March MA and Rubio-Valera M.
Estat actual de la recerca sobre la no-iniciació a nivell mundial i a Catalunya
Circular Farmaceutica . 77(3): 17-20.
-
Pérez A, Feliu A, Montero-Marín J, García-Campayo J, Andrés L, Borràs X, Rozadilla-Sacanell A, Peñarrubia-María MT, Angarita-Osorio N, McCracken LM and Luciano JV.
A randomized controlled efficacy trial of mindfulness-based stress reduction compared with an active control group and usual care for fibromyalgia: the EUDAIMON study
Pain . 160(11): 2508-2523. Nº de cites: 54
-
Pérez A, Francesco D'Amico, Feliu A, McCracken LM, Peñarrubia-María MT, Andrés L, Angarita-Osorio N, Martin Knapp, García-Campayo J and Luciano JV.
Cost-Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study)
Journal of Clinical Medicine . 8(7): . Nº de cites: 20
-
Rubio-Valera M, Peñarrubia-María MT, Iglesias M, Martin Knapp, Pau McCrone, Roig M, Sabes R, Luciano JV, Mendive JM, Murrugara-Centurión AG, Alonso J and Serrano-Blanco A.
Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).
EUROPEAN JOURNAL OF HEALTH ECONOMICS . 20(5): 703-713. Nº de cites: 3